Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis: Multicenter study in Argentina

Author:

Rojas Juan Ignacio1,Patrucco Liliana2,Alonso Ricardo3,Garcea Orlando4,Deri Norma5,Carnero Contentti Edgar6,Lopez Pablo A6,Pettinicchi Juan Pablo6,Caride Alejandro6,Cristiano Edgardo7

Affiliation:

1. Centro de Esclerosis Múltiple de Buenos Aires, Buenos Aires, Argentina/Servicio de Neurología, Hospital Universitario CEMIC, Buenos Aires, Argentina

2. Centro de Esclerosis Múltiple de Buenos Aires, Buenos Aires, Argentina/Servicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

3. Centro Universitario de Esclerosis Múltiple, Hospital Ramos Mejía, Buenos Aires, Argentina/Servicio de Neurología, Hospital Universitario Sanatorio Guemes, Buenos Aires, Argentina

4. Centro Universitario de Esclerosis Múltiple, Hospital Ramos Mejía, Buenos Aires, Argentina

5. Centro de Investigaciones Diabaid, CABA, Buenos Aires, Argentina

6. Neuroimmunology Unit, Department of Neuroscience, Hospital Aleman, Buenos Aires, Argentina

7. Centro de Esclerosis Múltiple de Buenos Aires, Buenos Aires, Argentina

Abstract

Background: A period of diagnostic uncertainty often characterizes the clinical transition from relapsing to secondary progressive multiple sclerosis (SPMS). Objective: The aim of this study was to describe the length of time required to reclassify relapsing-remitting MS (RRMS) patients who have clinically transitioned to SPMS (diagnosis uncertainty). Methods: This is a retrospective multicenter cohort study conducted in Argentina, identifying in every center all patients with diagnosis of MS who transitioned from RRMS to SPMS during the follow-up. We identified the dates of the last definitive RRMS and first definitive SPMS diagnoses for diagnostic uncertainty. The time required to reclassify RRMS who transitioned to SPMS and the time from disease onset to reclassify SPMS were calculated using the Kaplan–Meier method. Results: A total of 170 patients were included, where the mean age at disease onset (first symptom) was 36 ± 6 years; the length of time required to reclassify RRMS patients who transitioned to SPMS was 3.3 ± 1.1 years (range = 1–7 years); and the time from disease onset to classify SPMS was 19.4 ± 8.5 years (range = 16–35 years). Conclusion: A period of diagnostic uncertainty regarding the transition from RRMS to SPMS was present in many of our patients, with a mean time of 3.3 years.

Funder

novartis

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3